PineBridge Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,222
| Closed | -$2.26M | – | 710 |
|
|
2024
Q3 | $2.26M | Sell |
8,222
-688
| -8% | -$189K | 0.02% | 440 |
|
|
2024
Q2 | $2.17M | Sell |
8,910
-4,442
| -33% | -$1.08M | 0.02% | 377 |
|
|
2024
Q1 | $1.99M | Buy |
13,352
+3,171
| +31% | +$474K | 0.02% | 413 |
|
|
2023
Q4 | $1.95M | Buy |
10,181
+2,805
| +38% | +$537K | 0.02% | 376 |
|
|
2023
Q3 | $1.31M | Buy |
+7,376
| New | +$1.31M | 0.01% | 416 |
|